| Year |
Citation |
Score |
| 2018 |
Valentine FT, Golomb FM, Harris M, Roses DF. A novel immunization strategy using cytokine/chemokines induces new effective systemic immune responses, and frequent complete regressions of human metastatic melanoma. Oncoimmunology. 7: e1386827. PMID 29308310 DOI: 10.1080/2162402X.2017.1386827 |
0.328 |
|
| 2016 |
Valentine FT, Golomb FM, Haris M, Roses DF. Abstract A038: The feasibility of inducing effective systemic immune responses to human metastatic melanoma with intralesional secreted cytokines Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A038 |
0.325 |
|
| 2015 |
Gornalusse GG, Mummidi S, Gaitan AA, Jimenez F, Ramsuran V, Picton A, Rogers K, Manoharan MS, Avadhanam N, Murthy KK, Martinez H, Molano Murillo A, Chykarenko ZA, Hutt R, Daskalakis D, ... ... Valentine FT, et al. Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor. Proceedings of the National Academy of Sciences of the United States of America. 112: E4762-71. PMID 26307764 DOI: 10.1073/Pnas.1423228112 |
0.399 |
|
| 2012 |
Sivapalasingam S, Ahmed A, Mendillo M, Holzman R, Marshed F, Mwamzuka M, Khamadi S, Mwau M, Laverty M, Valentine F. Early detection of HIV infection among kenyan infants using a reverse transcriptase activity assay Pediatric Infectious Disease Journal. 31: 732-735. PMID 22581226 DOI: 10.1097/Inf.0B013E318259Bc1E |
0.465 |
|
| 2011 |
Mehta SA, Ahmed A, Laverty M, Holzman RS, Valentine F, Sivapalasingam S. Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 490-6. PMID 21844033 DOI: 10.1093/Cid/Cir432 |
0.481 |
|
| 2010 |
Mehta SA, Ahmed A, Kariuki BW, Said S, Omasete F, Mendillo M, Laverty M, Holzman R, Valentine F, Sivapalasingam S. Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya. The American Journal of Tropical Medicine and Hygiene. 83: 565-70. PMID 20810821 DOI: 10.4269/Ajtmh.2010.09-0629 |
0.443 |
|
| 2010 |
Sabado RL, O'Brien M, Subedi A, Qin L, Hu N, Taylor E, Dibben O, Stacey A, Fellay J, Shianna KV, Siegal F, Shodell M, Shah K, Larsson M, Lifson J, ... ... Valentine F, et al. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood. 116: 3839-52. PMID 20693428 DOI: 10.1182/Blood-2010-03-273763 |
0.479 |
|
| 2010 |
Twigg HL, Schnizlein-Bick CT, Weiden M, Valentine F, Wheat J, Day RB, Rominger H, Zheng L, Collman RG, Coombs RW, Bucy RP, Rezk NL, Kashuba AD. Measurement of antiretroviral drugs in the lungs of HIV-infected patients. Hiv Therapy. 4: 247-251. PMID 20436781 DOI: 10.2217/Hiv.10.5 |
0.487 |
|
| 2010 |
Silvera R, Stein D, Hutt R, Hagerty R, Daskalakis D, Valentine F, Marmor M. The Development and Implementation of an Outreach Program to Identify Acute and Recent HIV Infections in New York City. The Open Aids Journal. 4: 76-83. PMID 20386719 DOI: 10.2174/1874613601004010076 |
0.468 |
|
| 2010 |
El Hed A, Khaitan A, Kozhaya L, Manel N, Daskalakis D, Borkowsky W, Valentine F, Littman DR, Unutmaz D. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. The Journal of Infectious Diseases. 201: 843-54. PMID 20144043 DOI: 10.1086/651021 |
0.43 |
|
| 2010 |
Kelker HC, Itri VR, Valentine FT. A strategy for eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein. Plos One. 5: e8555. PMID 20052405 DOI: 10.1371/Journal.Pone.0008555 |
0.709 |
|
| 2009 |
Sivapalasingam S, Wangechi B, Marshed F, Laverty M, Essajee S, Holzman RS, Valentine F. Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: Evaluation of a low-cost viral load assay Plos One. 4. PMID 19714253 DOI: 10.1371/Journal.Pone.0006828 |
0.37 |
|
| 2009 |
Daskalakis D, Silvera R, Bernstein K, Stein D, Hagerty R, Hutt R, Maillard A, Borkowsky W, Aberg J, Valentine F, Marmor M. Implementation of HIV testing at 2 New York City bathhouses: from pilot to clinical service. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 1609-16. PMID 19400690 DOI: 10.1086/598979 |
0.445 |
|
| 2009 |
Kelker H, Itri V, Valentine F. P05-08. Eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein gp120: A strategy Retrovirology. 6: 84. DOI: 10.1186/1742-4690-6-S3-P84 |
0.718 |
|
| 2008 |
Blaser MJ, Valentine FT. Viral commensalism in humans? Journal of Infectious Diseases. 198: 1-3. PMID 18544010 DOI: 10.1086/588705 |
0.322 |
|
| 2008 |
Twigg Iii HL, Weiden M, Valentine F, Schnizlein-Bick CT, Bassett R, Zheng L, Wheat J, Day RB, Rominger H, Collman RG, Fox L, Brizz B, Dragavon J, Coombs RW, Bucy RP, et al. Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. The Journal of Infectious Diseases. 197: 109-16. PMID 18171293 DOI: 10.1086/523766 |
0.453 |
|
| 2007 |
Sivapalasingam S, Patel U, Itri V, Laverty M, Mandaliya K, Valentine F, Essajee S. A reverse transcriptase assay for early diagnosis of infant HIV infection in resource-limited settings Journal of Tropical Pediatrics. 53: 355-358. PMID 17562687 DOI: 10.1093/Tropej/Fmm032 |
0.476 |
|
| 2007 |
Sivapalasingam S, Kennedy JS, Borkowsky W, Valentine F, Zhan MX, Pazoles P, Paolino A, Ennis FA, Steigbigel NH. Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus. The Journal of Infectious Diseases. 195: 1151-9. PMID 17357051 DOI: 10.1086/512161 |
0.372 |
|
| 2006 |
Siddique MA, Hartman KE, Dragileva E, Dondero M, Gebretsadik T, Shintani A, Peiperl L, Valentine F, Kalams SA. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy. The Journal of Infectious Diseases. 194: 661-5. PMID 16897665 DOI: 10.1086/505913 |
0.495 |
|
| 2005 |
Sivapalasingam S, Essajee S, Nyambi PN, Itri V, Hanna B, Holzman R, Valentine F. Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings. Journal of Clinical Microbiology. 43: 3793-6. PMID 16081912 DOI: 10.1128/Jcm.43.8.3793-3796.2005 |
0.479 |
|
| 2004 |
Frank I, Bosch RJ, Fiscus S, Valentine F, Flexner C, Segal Y, Ruan P, Gulick R, Wood K, Estep S, Fox L, Nevin T, Stevens M, Eron JJ. Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307. Aids Research and Human Retroviruses. 20: 916-26. PMID 15597521 DOI: 10.1089/Aid.2004.20.916 |
0.422 |
|
| 2004 |
Vogler MA, Teppler H, Gelman R, Valentine F, Lederman MM, Pomerantz RJ, Pollard RB, Cherng DW, Gonzalez CJ, Squires KE, Frank I, Mildvan D, Mahon LF, Schock B. Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248). Journal of Acquired Immune Deficiency Syndromes (1999). 36: 576-87. PMID 15097300 DOI: 10.1097/00126334-200405010-00005 |
0.504 |
|
| 2003 |
Lederman HM, Williams PL, Wu JW, Evans TG, Cohn SE, McCutchan JA, Koletar SL, Hafner R, Connick E, Valentine FT, McElrath MJ, Roberts NJ, Currier JS. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. The Journal of Infectious Diseases. 188: 1794-803. PMID 14673757 DOI: 10.1086/379900 |
0.446 |
|
| 2003 |
Lalezari JP, DeJesus E, Northfelt DW, Richmond G, Wolfe P, Haubrich R, Henry D, Powderly W, Becker S, Thompson M, Valentine F, Wright D, Carlson M, Riddler S, Haas FF, et al. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults. Antiviral Therapy. 8: 279-87. PMID 14518696 |
0.351 |
|
| 2003 |
Lalezari JP, Eron JJ, Carlson M, Cohen C, DeJesus E, Arduino RC, Gallant JE, Volberding P, Murphy RL, Valentine F, Nelson EL, Sista PR, Dusek A, Kilby JM. A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. Aids (London, England). 17: 691-8. PMID 12646792 DOI: 10.1097/00002030-200303280-00007 |
0.468 |
|
| 2002 |
Kilby JM, Lalezari JP, Eron JJ, Carlson M, Cohen C, Arduino RC, Goodgame JC, Gallant JE, Volberding P, Murphy RL, Valentine F, Saag MS, Nelson EL, Sista PR, Dusek A. The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. Aids Research and Human Retroviruses. 18: 685-93. PMID 12167274 DOI: 10.1089/088922202760072294 |
0.49 |
|
| 2002 |
Skurnick JH, Palumbo P, DeVico A, Shacklett BL, Valentine FT, Merges M, Kamin-Lewis R, Mestecky J, Denny T, Lewis GK, Lloyd J, Praschunus R, Baker A, Nixon DF, Stranford S, et al. Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. The Journal of Infectious Diseases. 185: 428-38. PMID 11865394 DOI: 10.1086/338830 |
0.54 |
|
| 2001 |
Günthard HF, Havlir DV, Fiscus S, Zhang ZQ, Eron J, Mellors J, Gulick R, Frost SD, Brown AJ, Schleif W, Valentine F, Jonas L, Meibohm A, Ignacio CC, Isaacs R, et al. Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. The Journal of Infectious Diseases. 183: 1318-27. PMID 11294662 DOI: 10.1086/319864 |
0.475 |
|
| 2000 |
Gulick RM, Mellors JW, Havlir D, Eron JJ, Meibohm A, Condra JH, Valentine FT, McMahon D, Gonzalez C, Jonas L, Emini EA, Chodakewitz JA, Isaacs R, Richman DD. 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. Annals of Internal Medicine. 133: 35-9. PMID 10877738 DOI: 10.7326/0003-4819-133-1-200007040-00007 |
0.53 |
|
| 1999 |
Katzenstein DA, Kundu S, Spritzler J, Smoller BR, Haszlett P, Valentine F, Merigan TC. Delayed-type hypersensitivity to recombinant HIV envelope glycoprotein (rgp160) after immunization with homologous antigen. Journal of Acquired Immune Deficiency Syndromes (1999). 22: 341-7. PMID 10634195 DOI: 10.1097/00126334-199912010-00004 |
0.492 |
|
| 1999 |
Gulick RM, McAuliffe V, Holden-Wiltse J, Crumpacker C, Liebes L, Stein DS, Meehan P, Hussey S, Forcht J, Valentine FT. Phase I studies of hypericin, the active compound in St. John's wort, as an antiretroviral agent in HIV-infected adults: AIDS clinical trials group protocols 150 and 258 Annals of Internal Medicine. 130: 510-514. PMID 10075619 DOI: 10.7326/0003-4819-130-6-199903160-00015 |
0.529 |
|
| 1997 |
Kundu SK, Katzenstein D, Valentine FT, Spino C, Efron B, Merigan TC. Effect of therapeutic immunization with recombinant gp160 HIV-1 vaccine on HIV-1 proviral DNA and plasma RNA: relationship to cellular immune responses. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 15: 269-74. PMID 9292585 DOI: 10.1097/00042560-199708010-00004 |
0.5 |
|
| 1997 |
Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA, Deutsch P, Holder D, Schleif WA, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy New England Journal of Medicine. 337: 734-739. PMID 9287228 DOI: 10.1056/Nejm199709113371102 |
0.499 |
|
| 1996 |
Valentine FT, Kundu S, Haslett PA, Katzenstein D, Beckett L, Spino C, Borucki M, Vasquez M, Smith G, Korvick J, Kagan J, Merigan TC. A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137). The Journal of Infectious Diseases. 173: 1336-46. PMID 8648205 DOI: 10.1093/Infdis/173.6.1336 |
0.55 |
|
| 1995 |
Nardelli B, Gonzalez CJ, Schechter M, Valentine FT. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells Proceedings of the National Academy of Sciences of the United States of America. 92: 7312-7316. PMID 7638187 DOI: 10.1073/Pnas.92.16.7312 |
0.411 |
|
| 1993 |
Lambert JS, Seidlin M, Valentine FT, Reichman RC, Dolin R. Didanosine: long-term follow-up of patients in a phase 1 study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 16: S40-5. PMID 8093846 DOI: 10.1093/Clinids/16.Supplement_1.S40 |
0.343 |
|
| 1992 |
Kelker HC, Seidlin M, Vogler M, Valentine FT. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. Aids Research and Human Retroviruses. 8: 1355-9. PMID 1466956 DOI: 10.1089/Aid.1992.8.1355 |
0.732 |
|
| 1992 |
Drusano GL, Yuen GJ, Lambert JS, Seidlin M, Dolin R, Valentine FT. Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection: A phase I trial Annals of Internal Medicine. 116: 562-566. PMID 1347442 DOI: 10.7326/0003-4819-116-7-562 |
0.43 |
|
| 1990 |
Lambert JS, Seidlin M, Reichman RC, Plank CS, Laverty M, Morse GD, Knupp C, McLaren C, Pettinelli C, Valentine FT. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial. The New England Journal of Medicine. 322: 1333-40. PMID 2139173 DOI: 10.1056/Nejm199005103221901 |
0.349 |
|
| 1990 |
Valentine FT, Mindell S, Hochster H, Laverty M. Phase I study of 2′,3′-dideoxyinosine: experience with 19 patients at New York university medical center Reviews of Infectious Diseases. 12: S534-S539. PMID 1974725 DOI: 10.1093/Clinids/12.Supplement_5.S534 |
0.382 |
|
| 1990 |
Valentine FT. Pathogenesis of the immunological deficiencies caused by infection with the human immunodeficiency virus. Seminars in Oncology. 17: 321-334. DOI: 10.5555/Uri:Pii:0093775490900204 |
0.339 |
|
| 1990 |
Valentine FT, Jacobson MA. Immunological and virological surrogate markers in the evaluation of therapies for HIV infection. Aids. 4. DOI: 10.1097/00002030-199001001-00032 |
0.486 |
|
| 1989 |
Chachoua A, Green MD, Valentine F, Muggia FM. Phase I/II Trial of Thymostimulin in Opportunistic Infections of the Acquired Immune Deficiency Syndrome Cancer Investigation. 7: 225-229. PMID 2790539 DOI: 10.3109/07357908909039841 |
0.338 |
|
| 1989 |
Lavie G, Valentine F, Levin B, Mazur Y, Gallo G, Lavie D, Weiner D, Meruelo D. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proceedings of the National Academy of Sciences of the United States of America. 86: 5963-7. PMID 2548193 DOI: 10.1073/Pnas.86.15.5963 |
0.31 |
|
| 1976 |
Cohen L, Holzman RS, Valentine FT, Lawrence HS. Requirement of precommitted cells as targets for the augmentation of lymphocyte proliferation by leukocyte dialysates. Journal of Experimental Medicine. 143: 791-804. PMID 56417 DOI: 10.1084/Jem.143.4.791 |
0.35 |
|
| 1974 |
Ascher MS, Schneider WJ, Valentine FT, Lawrence HS. In vitro properties of leukocyte dialysates containing transfer factor. Proceedings of the National Academy of Sciences of the United States of America. 71: 1178-1182. PMID 4524630 DOI: 10.1073/Pnas.71.4.1178 |
0.31 |
|
| 1969 |
Marshall WH, Valentine FT, Lawrence HS. Cellular Immunity In Vitro : Clonal Proliferation Of Antigen-Stimulated Lymphocytes Journal of Experimental Medicine. 130: 327-343. PMID 4893888 DOI: 10.1084/Jem.130.2.327 |
0.307 |
|
| Show low-probability matches. |